RxDoctor Payments Data

Jaya Sharma

Family · New York, NYNPI 1124761911

Payments from drug & device makers

$577in general payments, 2019–2025

Across 26 payments — averaging $22.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$125
  • Kaleo, Inc.$106
  • GSK$79
  • AstraZeneca$72
  • Lilly USA, LLC$69
  • Regeneron Healthcare Solutions, Inc.$39
  • plus $87 from 4 others

What the payments were for

  • Food & beverage$577100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$577 in reported general payments places this provider in the 60th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$6,235
Medicare patients
36
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Zolpidem Tartrate13$105

Paid to pharmacies, not to this prescriber.

Other family in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →